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Abstract
Purpose In an earlier randomised controlled trial, we
showed that early stage breast cancer patients who received
a supervised exercise programme, with discussion of behav-
iour change techniques, had psychological and functional
benefits 6 months after the intervention. The purpose of this
study was to determine if benefits observed at 6 months
persisted 18 and 60 months later.
Methods Women who were in the original trial were con-
tacted at 18 and 60 months after intervention. Original
measures were repeated.
Results Of the 148 women from the original study who
agreed to be contacted again, 114 attended for follow-up at
18 months and 87 at 60 months. Women in the original
intervention group reported more leisure time physical ac-
tivity and more positive moods at 60 months than women in
the original control group. Irrespective of original group
allocation, women who were more active consistently
reported lower levels of depression and increased quality
of life compared to those who were less active.
Conclusions We have shown that there are lasting benefits
to an exercise intervention delivered during treatment to
breast cancer survivors. Regular activity should be encour-
aged for women with early stage breast cancer as this can
have lasting implications for physical and psychological
functioning.
Keywords Breast cancer survivors . Physical activity .
Five-year follow-up . Quality of life
Introduction and background
Worldwide, approximately 1.38 million women are diag-
nosed with breast cancer each year [1]. In developed
countries, 80 % of women with breast cancer will survive
at least 60 months due to early detection techniques and
effective anti-cancer treatments. In the UK, there are cur-
rently around 550,000 breast cancer survivors [2].
Breast cancer treatments can cause chronic side effects
such as oestrogen deprivation symptoms, athralgias, fatigue,
lymphoedema, peripheral neuropathy, reduced bone health,
Trial registration Current controlled trials ISRCTN12587864.
N. Mutrie
School of Psychological Sciences and Health,
University of Strathclyde,
76 Southbrae Drive,
Glasgow G13 1PP, UK
A. Campbell
Institute of Sport and Exercise, University of Dundee,
Dundee, UK
S. Barry :A. McConnachie
Robertson Centre for Biostatistics, University of Glasgow,
Glasgow, UK
K. Hefferon
School of Psychology, University of East London,
London, UK
D. Ritchie
Beatson West of Scotland Cancer Centre,
1052 Great Western Road,
Glasgow G12 0YN, UK
S. Tovey
Crosshouse Hospital,
Kilmarnock KA2 0BE, UK
Present Address:
N. Mutrie (*)
Institute of Sport, Physical Education and Health Sciences,
University of Edinburgh,
Holyrood Road,
Edinburgh EH8 8AQ, UK
e-mail: nanette.mutrie@ed.ac.uk
J Cancer Surviv (2012) 6:420–430
DOI 10.1007/s11764-012-0233-y
upper extremity functional impairments and overall func-
tional decline [3]. A considerable number of breast cancer
survivors experience some of these side effects although
there is currently no accurate quantitative data on the inci-
dence of these symptoms. The evidence that exercise is
effective in treating many of these chronic or late appearing
side effects is compelling: a recent systematic review and
meta-analysis supported the use of exercise to prevent or
treat fatigue and lymphoedema and to improve functional
status and upper body range of movement [4]. In addition,
prospective observational studies suggest that around 3 h of
aerobic activity per week can significantly reduce the risk of
cancer recurrence and breast cancer mortality [5]. There is
now a need for randomised controlled trials (RCTs) to
examine the long-term effects of exercise interventions for
improving outcomes such as quality of life, symptom man-
agement and ultimately cancer recurrence and mortality. To
date, the longest follow-up with cancer survivors after an
exercise intervention is 2 years [6], with most RCTs only
following participants up to 6 months post intervention [7].
The aim of this study was to follow-up participants from a
RCT during adjuvant treatment 18 and 60 months after the
exercise intervention.
The original study’s aim was to determine if there were
functional and psychological benefits of a 12-week super-
vised group exercise programme during treatment for early
stage breast cancer, including a 6-month follow-up. The
study was designed as a pragmatic randomised controlled
prospective open trial and was set in three oncology clinics
in Scotland for recruitment and in community facilities for
the exercise intervention. The participants were 203 women
with breast cancer with 177 completing the 6-month follow-
up. The intervention incorporated a variety of safe cardio-
vascular, muscular strength and flexibility exercises and
group discussion of exercise behaviour change techniques,
in addition to usual care. The control group received usual
care until the 6-month follow-up when they had a one to one
discussion about how to incorporate physical activity into
their lifestyle. Details of the methods and results are
reported in more detail elsewhere [8]. The main outcome
measures were: Quality of Life (FACT) questionnaire, Beck
Depression Inventory (BDI), positive and negative affect
scale (PANAS), body mass index (BMI), 7-day recall of
physical activity from the Scottish Physical Activity
Questionnaire-2 (SPAQ), 12-min walk test and assessment
of shoulder mobility. The results showed significant inter-
vention effects at 12 weeks and 6 months follow-up for
metres walked in 12 min, minutes of moderate intensity
activity reported in a week, shoulder mobility, breast cancer
specific subscale of quality of life and for positive mood. It
was concluded that a supervised group exercise programme
provided functional and psychological benefit after a 12-
week intervention and six months later.
The aim of the this follow-up study was
1. To determine if intervention effects continued after the
6-month follow-up
2. To determine if women who had higher levels of activ-
ity after diagnosis and treatment had a different func-
tional or psychological profile than women who had
lower levels of activity and to elicit views from the
women concerning their experience of physical activity
post intervention
However, in this paper, we will not report on the quali-
tative analysis of the women’s views. The methods and
results for that qualitative aspect will be reported elsewhere.
Method
Participants
All women who had participated in the original study and
who had agreed to being contacted again (n0148) were
contacted at 18 months after the intervention and invited
to participate in the follow-up study. Sixty months after the
intervention, all women (regardless of 18-month participa-
tion) were contacted again and invited to participate in a
further follow-up.
Procedures
Each woman’s General Practitioner (GP) was contacted
to ensure it was appropriate to write to the participant.
Eligible participants were sent a letter inviting them to
take part. Women who agreed to take part were then
contacted by telephone to arrange for reassessment at
the local sports facility where the original assessments
had been carried out. All procedures and outcome meas-
ures were identical to the original study. Each appoint-
ment lasted approximately 2 h. All procedures were
approved by the local NHS research ethics committee
and informed consent obtained.
Data analysis
In the original study, the participants were seen at the
beginning and end of the exercise intervention period (i.e.
baseline and 3 months) and at the 6-month follow-up (i.e.
6 months from the end of the intervention period). In this
study, we add 18 and 60-month follow-up time points.
At each time point, the participants self-reported the total
number of minutes of leisure time activity undertaken in the
previous week, using a validated questionnaire (SPAQ). At
each time point, they were classified as ‘more’ or ‘less’
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active if they were above or below, respectively, the sample
median leisure time activity for their age group.
Baseline demographics were summarised and compared
for those who had and had not dropped out of the study at
each follow-up time point.
The effect of the intervention on change from baseline in
each outcome was modelled over time using a linear mixed
effects model with a random intercept for subject, adjusting
for study site, therapy received at baseline and age. The
mean difference in change from baseline between the inter-
vention groups at each time point was estimated with a 95 %
confidence interval (CI) and p value. The model implicitly
accounts for missing data by considering the individual
trends over time as well as the observed group means at
each time point to give a more accurate estimate (than the
observed group mean alone) of the population group means
over time. For example, if women with lower scores at
earlier time points tend to be more likely to drop out later,
then the estimated mean at later time points will be adjusted
downwards slightly to account for this.
The differences in the outcomes at each time point be-
tween the more and less active group were estimated using
similar models, additionally adjusting for intervention
group. Note that it was not possible to consider change from
baseline for this comparison because women were not nec-
essarily in the same activity groups at different time points
and so the outcomes were the actual scores rather than
change from baseline.
Results
Demographics
One hundred and fourteen women attended follow-up at
18 months and 87 women attended at 60 months. The
flow of participants through this follow-up study is
shown in Fig. 1 (see reference 8 for the flow diagram
for the original study). Similar numbers of women in
each study treatment group participated at 60 months.
Baseline demographic characteristics of those that took
part in the study at the 18 and 60-month follow-up
versus those that did not are shown in Table 1. Those
who participated in the follow-up at 60 months were, at
baseline, 3 years older and 5 kg lighter on average and
were faster walkers (i.e. probably fitter); and may have
been slightly less depressed and with less negative mood
than those who did not participate at 60 months. Women
in work prior to diagnosis and those that were less
deprived were more likely to participate than those who
were housewives or more deprived. There were no differ-
ences in the proportions of control and exercise group
women that responded at either 18 or 60 months.
Effects of the intervention
To determine if there were any lasting effects of the inter-
vention, comparisons were made between the original treat-
ment and control groups. We have already reported the
intervention benefits 6 months after intervention. Table 2
shows descriptive statistics of the outcome data at 18 and
60 months with corresponding treatment effect estimates.
There were significant differences between the intervention
and control groups at 60 months for SPAQ leisure time
activity over the previous week and PANAS positive mood
score with the intervention group reporting higher activity
and more positive mood. Even for outcomes for which there
was no significant difference at 60 months, the intervention
group was consistently observed to do better than the con-
trol group throughout the entire 5-year follow-up period.
The treatment effect estimates at 18 and 60 months are also
displayed in units of 1 standard deviation in Fig. 2 for all
outcomes measured and are of similar magnitude at both
time points. At 5 years, the intervention group achieved on
average around 200 min of activity each week more than the
control group (see Table 2 for related data). In general, our
analyses suggested that 5 years subsequent to taking part in
such an exercise intervention similar patients would be
likely to achieve on average 50 to 350 min of extra physical
activity per week than patients treated as usual. This is a
substantial difference which could lead to considerable
health benefit.
Adjusting for other baseline variables (such as depriva-
tion category, occupation prior to diagnosis, hysterectomy
status, work status) had negligible effect on the group differ-
ences for any of the outcomes, despite some of these base-
line variables showing strong relationships with the
outcomes and/or differing between women that were fol-
lowed up at 18 and 60 months and those that were not.
Associations with levels of self-reported activity
To determine if there were differences between those wom-
en who self-reported themselves as being ‘more’ active and
those who self-reported that they were ‘less’ active at each
follow-up point, comparisons were made between these two
categories of women, adjusting for original treatment group
(as well as baseline study site, therapy and age).
The model-estimated trends for the main outcomes over
all time points, with confidence intervals, are given in Figs. 3
and 4. Figure 3 illustrates that the more active group was
observed to walk a slightly longer distance in 12 min at
every follow-up time point, though the differences were not
significant.
The BDI score was marginally significantly different
between the groups at baseline and decreased for both
groups over time. A larger decrease in depression levels
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for the group identifying as active was associated with
significant differences at all follow-up points. BMI scores
were on average slightly lower for the active group through-
out the study, though the difference was statistically signif-
icant only at baseline and 12 weeks. There were statistically
significant differences between the activity groups for total
shoulder range of motion at baseline and 6 months follow-
up only, and the observed difference was not consistent over
time.
Figure 4 shows similar increases in FACT-G average
scores (and therefore quality of life improvements) for both
activity groups over time. In general, by 60 months follow-
up there were no statistically significant differences in any
of the quality of life scales, despite the consistency of the
observed difference over time.
PANAS negative was significantly lower in the more
active group at the end of the original study period and this
persisted out to 6 months follow-up, despite there being no
difference at baseline. This difference was not, however,
statistically significant at 18 or 60 months, though the ob-
served difference remained similar over time. Similarly, the
more active group had significantly higher PANAS positive
at baseline and at the end of the original study period and
though the magnitude of this difference was similar at
60 months, it was marginally non-significant (0.078). The
physical activity effects estimates, in units of 1 standard
deviation, are displayed in Fig. 5 for all of the outcomes at
18 and 60 months.
Discussion
This is the first study to examine the long-term effects of an
exercise intervention in a RCT with cancer survivors. The
number of women lost to follow-up at 18 (44 %) and
60 months (58 %) is higher than that observed in a 2-year
follow-up of a 6-month rehabilitation programme to reduce
lymphoedema after breast cancer surgery (27 %) [6] but
similar to that found in a longitudinal study of older breast
cancer survivors in a 6-year follow-up (50 %) [9]. Five years
after taking part in the study, women who were assigned to
the original intervention group, who had received the op-
portunity to attend a 12-week programme of supervised
group exercise and group discussion of behaviour change
issues, self-reported more leisure time activity and more
positive mood than those women originally assigned to the
control group condition. This is very encouraging as our
trial was designed to promote long-term exercise behaviour
change. Both the intervention and control groups self-
reported high levels of physical activity at 5 years exceeding
current public health recommendations of achieving
150 min of moderate activity in a week. Thus even the
control group has benefitted from being involved in this
project 5 years after diagnosis. However, as the data from
Table 2 shows, the intervention group reported around
200 min of activity more than the control group at 5 years,
and although there is also high variability in these data, this
is a statistically significant difference. The possibility of
Participants in original study 
(n=203 at baseline and n= 177 
at 6 month follow-up) 
Agreed to be contacted again 
(n= 148)  
Lost to 18 month follow up (n=34) 
Not contactable (n=19) 
Declined to participate (n=5) 
Deceased (n=10) 
Lost to 60 month follow-up (n= 33) 
Declined to participate (n=10) 
Deceased (n=10) 
Not contactable (n=9) 
Did not show (n=4) 
Agreed to participate after 18 month follow-up 
(n=81) 
Did not participate at 18 months but agreed at 60 
months (n= 6) 
Followed-up at 18months (n=114)
Allocated originally to intervention (n=58) 
Allocated originally to control (n=56) 
Followed–up at 60 months (n=87)
Allocated originally to intervention (n=44) 
Allocated originally to control (n=43) 
Fig. 1 Participant flow through
follow-up study
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Table 1 Demographics at baseline for women that took part in the
follow-up study (responders) and women that did not take part in the
follow-up study (non-responders) at each subsequent time point:
summary statistics and p values for differences between responders
and non-responders (Wilcoxon/Fisher’s test)
18 months 5 years
Responder p Responder p
No Yes No Yes
Age (years) n 87 114 <0.01 114 87 0.03
Mean (SD) 49.0 (9.2) 53.5 (9.3) 50.3 (9.5) 53.2 (9.3)
Baseline weight (kg) n 85 114 <0.01 112 87 <0.01
Mean (SD) 74.2 (15.5) 68.3 (13.3) 73.2 (15.2) 67.8 (13.2)
Height (cm) n 87 112 0.20 114 85 0.14
Mean (SD) 161.0 (6.3) 159.9 (6.0) 160.9 (6.3) 159.7 (5.9)
BDI score n 85 112 0.06 112 85 0.06
Mean (SD) 13.3 (7.2) 11.4 (7.1) 13.1 (7.5) 11.1 (6.6)
PANAS positive n 87 112 0.10 113 86 0.13
Mean (SD) 26.5 (8.4) 28.9 (9.0) 26.8 (8.6) 29.2 (8.9)
PANAS negative n 87 112 0.05 113 86 0.09
Mean (SD) 19.5 (7.9) 17.2 (6.8) 19.1 (7.8) 17.0 (6.5)
12-min walk (m) n 85 114 0.18 112 87 0.03
Mean (SD) 973.4
(220.8)
996.0 (224.8) 958.1 (242.4) 1,022.7
(190.0)
SPAQ leisure time activity (min) n 85 110 0.32 110 85 0.71
Mean (SD) 367.0
(330.3)
365.1 (267.9) 375.1 (323.2) 354.1 (257.7)
SRM total score n 87 114 0.80 114 87 0.98
Mean (SD) 30.7 (5.8) 30.8 (5.3) 30.6 (5.7) 30.9 (5.4)
BMI (kg/m2) n 85 112 0.01 112 85 0.02
Mean (SD) 28.6 (6.0) 26.8 (5.3) 28.3 (5.9) 26.6 (5.3)
Exercise group Control 46/102
(45.1)
56/102 (54.9) 0.67 59/102 (57.8) 43/102 (42.2) 0.78
Exercise 41/99 (41.4) 58/99 (58.6) 55/99 (55.6) 44/99 (44.4)
Study centre GRI 16/33 (48.5) 17/33 (51.5) 0.55 21/33 (63.6) 12/33 (36.4) 0.57
BOC 62/151
(41.1)
89/151 (58.9) 85/151 (56.3) 66/151 (43.7)
Other 9/17 (52.9) 8/17 (47.1) 8/17 (47.1) 9/17 (52.9)
Therapy Chemotherapy 7/15 (46.7) 8/15 (53.3) 0.52 7/15 (46.7) 8/15 (53.3) 0.67
Radiotherapy 21/57 (36.8) 36/57 (63.2) 32/57 (56.1) 25/57 (43.9)
Combination 59/129
(45.7)
70/129 (54.3) 75/129 (58.1) 54/129 (41.9)
Surgery type Mast only 31/57 (54.4) 26/57 ( 45.6) 0.18 38/57 (66.7) 19/57 ( 33.3) 0.20
Lump only 48/116
(41.4)
68/116 (
58.6)
65/116 (56.0) 51/116 ( 44.0)
Lump and Mast 1/2 (50.0) 1/2 ( 50.0) 1/2 (50.0) 1/2 ( 50.0)
Lump and
Recon
0/1 ( 0.0) 1/1 (100.0) 0/1 ( 0.0) 1/1 (100.0)
Mast and Recon 6/22 (27.3) 16/22 ( 72.7) 9/22 (40.9) 13/22 ( 59.1)
Other 1/2 (50.0) 1/2 ( 50.0) 1/2 (50.0) 1/2 ( 50.0)
Tamoxifen used No 57/117
(48.7)
60/117 (51.3) 0.08 72/117 (61.5) 45/117 (38.5) 0.15
Yes 30/83 (36.1) 53/83 (63.9) 42/83 (50.6) 41/83 (49.4)
Highest education level School 40/92 (43.5) 52/92 (56.5) 1.00 54/92 (58.7) 38/92 (41.3) 0.77
Other 43/99 (43.4) 56/99 (56.6) 55/99 (55.6) 44/99 (44.4)
Employment status (prior to
diagnosis)
FT/PT 10/29 (34.5) 19/29 (65.5) 0.01 11/29 (37.9) 18/29 (62.1) 0.02
Sick 52/111
(46.8)
59/111 (53.2) 66/111 (59.5) 45/111 (40.5)
Housewife 17/26 (65.4) 9/26 (34.6) 20/26 (76.9) 6/26 (23.1)
Retired 8/35 (22.9) 27/35 (77.1) 17/35 (48.6) 18/35 (51.4)
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over reporting physical activity because of the self-
report nature of the data must be acknowledged but
the difference between the two groups in terms of
physical activity is substantial. This suggests that the
experience of attending the group exercise sessions had
influenced the ability to sustain physical activity at a
high level for the intervention group. This increase in
physical activity could have important additional physi-
cal and mental well-being effects such as improved
mood which we have observed, and reduced risk of
recurrence of breast cancer, improved bone health and
biomarker levels (e.g. insulin pathway and inflamma-
tion) which were not measured in the original study.
An important element of the exercise programme
was the group discussions that happened at the end
of each class. Each week, for 6 weeks, a specific
theme was covered in group discussion after the exer-
cise (for example, the health benefits of exercise, en-
hancing self-efficacy and setting goals) and supported
with specifically constructed materials. These themes
were guided by a model of behaviour change and were
designed to promote independent exercise after the
intervention [10]. The six week block was repeated
on a rolling basis, allowing all participants to hear
the same themes. At the end of the 12-week interven-
tion, the women were helped to construct an individual
exercise programme. The control group received a
personal consultation after the 6-month follow-up
about how to increase physical activity levels. After
the final data collection, women from both groups who
expressed an interest in a local exercise referral
scheme were given information on how to attend.
The results show that the original intervention had a
long lasting effect on helping the intervention group
maintain a more physically active life. The difference
in physical activity level that we see at 60 months
between intervention and control group can be attrib-
uted to the experience of the class and group discus-
sion of behaviour change challenges and solutions.
In a study of cancer survivors diagnosed more than 5 years
ago [11], over 53% reported difficulties in crouching, standing
for 2 h, carrying 10 pounds and walking quarter of a mile—
compared to 21% of a matched sample with no cancer history.
This demonstrates the importance of helping cancer survivors
maintain basic levels of physical performance for simple ac-
tivities of daily living. Positive mood is an indication of
psychological well-being and may also be linked to increased
activity levels. Williams et al. [12] found that an acute positive
affective response to a single bout of moderate intensity exer-
cise predicted physical activity participation levels 6 and
12months later. This is consistent with other follow-up studies
[7] and recent meta-analysis [4] which suggest positive effects
of exercise on psychosocial parameters. Overall the pattern of
results suggests a range of benefits of participating in the
supervised exercise programme providing that the programme
includes discussion of behaviour change challenges and sol-
utions. The results therefore support the implementation of
exercise opportunities into cancer rehabilitation in the same
Table 1 (continued)
18months 5years
Responder p Responder p
No Yes No Yes
Occupation (prior to diagnosis) Professional 17/48 (35.4) 31/48 (64.6) 0.72 21/48 (43.8) 27/48 (56.2) 0.39
Managerial 14/35 (40.0) 21/35 (60.0) 18/35 (51.4) 17/35 (48.6)
Clerical 25/55 (45.5) 30/55 (54.5) 32/55 (58.2) 23/55 (41.8)
Manual 15/33 (45.5) 18/33 (54.5) 20/33 (60.6) 13/33 (39.4)
Carstairs’ deprivation 1–2 17/58 (29.3) 41/58 (70.7) 0.04 23/58 (39.7) 35/58 (60.3) 0.01
3–5 42/86 (48.8) 44/86 (51.2) 53/86 (61.6) 33/86 (38.4)
6–7 26/53 (49.1) 27/53 (50.9) 35/53 (66.0) 18/53 (34.0)
Periods No 70/169
(41.4)
99/169 (58.6) 0.36 95/169 (56.2) 74/169 (43.8) 0.74
Irregular 8/17 (47.1) 9/17 (52.9) 9/17 (52.9) 8/17 (47.1)
Regular 9/15 (60.0) 6/15 (40.0) 10/15 (66.7) 5/15 (33.3)
Hysterectomy No 80/179
(44.7)
99/179 (55.3) 0.36 101/179
(56.4)
78/179 (43.6) 1.00
Yes 7/22 (31.8) 15/22 (68.2) 13/22 (59.1) 9/22 (40.9)
HRT Never 58/124
(46.8)
66/124 (53.2) 0.31 73/124 (58.9) 51/124 (41.1) 0.69
Former 24/67 (35.8) 43/67 (64.2) 35/67 (52.2) 32/67 (47.8)
Current 5/10 (50.0) 5/10 (50.0) 6/10 (60.0) 4/10 (40.0)
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Table 2 Main outcomes: summary statistics at 18 and 60 months for the control and exercise intervention groups and model effect estimatesa of
treatment effect differences for change from baseline
Summaries at each time point Effect estimate (Exercise−Control)
Baseline 18 months 5 years 18M−Baseline 5Y−Baseline
FACT-G All n 201 114 87
Mean 74.4 80.7 87.1
(SD) (14.3) (14.6) (11.1)
Control n 102 56 43 2.2 0.9
Mean 72.7 79.6 85.7 (−1.8, 6.2) (−3.4, 5.2)
(SD) (15.6) (14.7) (11.4) 0.286 0.683
Exercise n 99 58 44
Mean 76.1 81.7 88.5
(SD) (12.6) (14.6) (10.7)
BDI score All n 197 114 87
Mean 12.2 9.3 7.0 −0.8 −0.2
(SD) (7.2) (7.7) (6.7) (−3.1, 1.5) (−2.8, 2.4)
Control n 98 56 43 0.495 0.857
Mean 12.9 9.7 7.5
(SD) (7.5) (7.7) (6.7)
Exercise n 99 58 44
Mean 11.5 8.9 6.6
(SD) (6.9) (7.8) (6.7)
PANAS positive All n 199 114 87
Mean 27.8 31.0 34.2
(SD) (8.8) (9.8) (8.3)
Control n 100 56 43 1.5 3.4
Mean 28.0 30.6 33.1 (−1.4, 4.3) (0.2, 6.7)
(SD) (9.2) (10.1) (8.7) 0.312 0.040
Exercise n 99 58 44
Mean 27.7 31.3 35.2
(SD) (8.4) (9.6) (7.8)
PANAS negative All n 199 114 87 −0.8 −0.5
Mean 18.2 16.7 15.4 (−2.9, 1.4) (−2.9, 1.8)
(SD) (7.4) (7.5) (5.3) 0.487 0.655
Control n 100 56 43
Mean 19.1 17.4 16.3
(SD) (7.7) (8.1) (5.6)
Exercise n 99 58 44
Mean 17.3 16.0 14.5
(SD) (6.9) (6.9) (5.0)
12-min walk All n 199 95 83
Mean 986 1,085 1,065
(SD) (223) (192) (158)
Control n 100 47 40 20 40
Mean 975 1,066 1,031 (−33, 74) (−16, 97)
(SD) (235) (169) (163) 0.463 0.164
Exercise n 99 48 43
Mean 997 1,104 1,096
(SD) (211) (213) (147)
SPAQ leisure time activity (min) All n 195 111 84 79 204
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way that exercise is now a mainstream component of cardiac
rehabilitation.
Irrespective of original group allocation, those who self-
reported as engaging in higher levels physical activity
recorded benefits on many of the quality of life and mood
variables in comparison to those who self-reported that they
were less active. This suggests that being active, regardless
of original group allocation to intervention or control con-
ditions, was associated with quality of life and mood bene-
fits. A 13-year follow-up of 374 women diagnosed with
breast cancer at a young age (<40) showed that the women
whose exercise activity increased following diagnosis
scored significantly higher (p00.005) on the SF-36 physical
health quality of life scale [13]. Likewise a prospective
study investigating physical activity and quality of life in
545 breast cancer survivors showed that greater physical
activity levels 3 years post diagnosis were related to less
fatigue and better physical functioning [14]. In general,
statistically significant differences are more apparent at 18-
month follow-up than at 60 months, though it is important to
note that the number of women responding at 60 months
was lower and the magnitude of the effect for several out-
comes is similar to the corresponding 18-month effect.
Strengths and limitations
This is first study to follow an intervention group for
60 months after an exercise intervention for women
with early stage breast cancer and our response rate is
similar to other studies of this length. A limitation is
that there were some differences in baseline demograph-
ics and outcome scores between those that did and did
not return for follow-up and a reasonably high rate of
dropout at 60 months. However, we used statistical
modelling methods that appropriately accounted for such
missing data to give reliable estimates of the population
Table 2 (continued)
Summaries at each time point Effect estimate (Exercise−Control)
Baseline 18months 5years 18M−Baseline 5Y−Baseline
Mean 366 533 557 (−48, 206) (54, 354)
(SD) (296) (355) (321) 0.222 0.008
Control n 99 55 41
Mean 365 500 462
(SD) (288) (334) (263)
Exercise n 96 56 43
Mean 367 565 648
(SD) (306) (373) (347)
SRM total score All n 201 110 86
Mean 30.7 32.4 32.8
(SD) (5.5) (5.3) (5.1)
Control n 102 53 43 0.3 1.2
Mean 30.3 31.7 31.8 (−1.1, 1.7) (−0.3, 2.7)
(SD) (5.7) (5.6) (5.9) 0.652 0.109
Exercise n 99 57 43
Mean 31.2 33.1 33.8
(SD) (5.4) (5.0) (3.9)
BMI All n 197 111 85 −0.3 −0.6
Mean 27.6 27.5 27.3 (−1.2, 0.7) (−1.6, 0.4)
(SD) (5.7) (5.1) (5.4) 0.546 0.222
Control n 100 56 43
Mean 27.7 28.0 28.0
(SD) (6.1) (6.4) (6.7)
Exercise n 97 55 42
Mean 27.4 26.9 26.7
(SD) (5.3) (3.3) (3.7)
18M 18 months follow-up, 5Y 60 months follow-up
a Effects estimates are displayed as the mean estimate, 95 % confidence interval and p value. Model adjusted for study site, baseline therapy and age
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group means and corresponding differences over time,
and we adjusted the models for baseline demographics.
Physical activity measures in this study were self-
reported and future studies should attempt objective
monitoring of physical activity patterns including seden-
tary time.
Conclusions
Some of the benefits of a supervised exercise programme
that incorporated discussion of behaviour change techni-
ques, which were reported 6 months following the original
intervention, have remained 60 months after the original
Fig. 3 Model-estimated mean 12-min walk distance, Beck depression
inventory score, BMI and shoulder range of motion score over time for
the more and less active groups, adjusted for original study site,
therapy received at baseline and baseline age, with p values for tests
of differences between the groups at each time point
Fig. 2 Exercise treatment effect estimates for all outcomes at 18 and 60 months, adjusted for original study site, therapy received at baseline and
baseline age, with 95 % confidence intervals (CIs) and corresponding p values at the right hand side
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study ended. These include higher levels of self-reported leisure
time activity and more positive mood for the intervention group
in comparison to the original control group. Categorising the
women by self-reported activity status, rather than by original
allocation to intervention and control conditions, also shows
benefits over time in terms of lower levels of depression and
higher levels of mood and quality of life for those who report
being more active. Cancer survivors should be encouraged to
engage in regular physical activity and to work towards achiev-
ing the public health recommendations for sufficient physical
activity during and after treatment for early stage breast cancer
[15, 16]. Services to support regular physical activity might
Fig. 5 Physical activity effect estimates for all outcomes at 18 and 60 months, adjusted for original study site, therapy received at baseline and
baseline age, with 95 % confidence intervals (CIs) and corresponding p values at the right hand side
Fig. 4 Model-estimated mean FACT-G, FACT-B subscale, PANAS
positive and PANAS negative scores over time for the more and less
active groups, adjusted for original study site, therapy received at
baseline and baseline age, with p values for tests of differences be-
tween the groups at each time point
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include supervised exercise sessions in early stages, similar to
that provided for cardiac rehabilitation, and encouragement to
make use of local physical activity opportunities.
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